Company news
Pharmaengine, Inc. (TPEX:4162) news
Pharmaengine, Inc. news releases on 6ix. Latest, Sep 9, 2025: XtalPi AI Drug Discovery Collaboration Reaches Milestone as PharmaEngine's Novel PRMT5 Inhibitor…
Press releases & updates
XtalPi AI Drug Discovery Collaboration Reaches Milestone as PharmaEngine's Novel PRMT5 Inhibitor PEP08 Receives Clinical Trial Approvals
September 9, 2025
PharmaEngine : Phase III RESILIENT trial evaluating Onivyde in second-line monotherapy for small cell lung cancer did not meet its primary endpoint
August 3, 2022
PharmaEngine : to attend 1H22 financial status investor conference hosted by Cathay Securities
July 26, 2022
PharmaEngine : announces the board resolutions on approving the Second Quarter of 2022 consolidated financial report
July 26, 2022
PharmaEngine : Announcement on the record date for the capital increase of Employee Restricted Shares and related matters
July 26, 2022
PharmaEngine : Announcement of the resolution by the company’s board of directors for the ex-dividend record date of cash dividends
July 26, 2022
PharmaEngine : The Company announced the new-elected members of the Compensation Committee
May 27, 2022
PharmaEngine : The Company announced the new-elected members of the Audit Committee
May 27, 2022
PharmaEngine : Important resolutions of the Company's 2022 Annual Shareholders' Meeting
May 27, 2022
PharmaEngine : Announcement of the new chairperson of The Company
May 27, 2022
PharmaEngine : Announcement of the 2022 shareholders' meeting resolution of new-elected 9 directors (including 3 independent directors)
May 27, 2022
PharmaEngine : to attend Cathay Securities Investor Conference hosted by Cathay Securities
April 28, 2022
PharmaEngine : announces the board resolutions on approving the First Quarter of 2022 consolidated financial report.
April 28, 2022
PharmaEngine : announced that the China NMPA has granted approval for ONIVYDE Regimen for the Treatment of Metastatic Pancreatic Cancer
April 15, 2022
PharmaEngine : to attend Yuanta Securities Investor Conference hosted by Yuanta Securities
March 8, 2022
PharmaEngine : Announcement that the Company's Board of Directors resolved to issue restricted stock awards (RSA)
March 8, 2022
PharmaEngine : announces the board resolutions on approving the Full Year of 2021 consolidated financial report.
March 8, 2022
PharmaEngine : Announcement of cancellation of the Company treasury shares and change of paid-in capital registration
March 1, 2022
PharmaEngine : to attend QIC Healthcare Forum hosted by Quantum International CORP.
February 10, 2022